Literature DB >> 11348881

Identification of a gamma-interferon-responsive element in the promoter of the human macrophage scavenger receptor A gene.

T Grewal1, E Priceputu, J Davignon, L Bernier.   

Abstract

In the present study, we demonstrate gamma-interferon (gamma-IFN)-inducible scavenger receptor A (SR-A) mRNA expression during the early stages of THP-1 and blood monocyte differentiation. Predominant induction of SR-A type II mRNA parallels the increased accumulation of cholesteryl esters under these conditions. A potential signal transducer and activator of transcription (STAT1) binding site (gamma-interferon activation site) in the SR-A promoter demonstrates gamma-IFN-inducible DNA binding activity and is most likely responsible for the gamma-IFN-dependent expression of an SR-A promoter-luciferase fusion construct. In contrast, gamma-IFN inhibits SR-A expression in mature macrophages as well as after prolonged gamma-IFN incubation of THP-1 monocytes. Taken together, these results demonstrate opposite effects of gamma-IFN on SR-A expression and activity during the early versus late stages of monocyte maturation. gamma-IFN-induced STAT1 activation, leading to increased SR-A expression, could therefore play an important role in the initial steps of foam cell formation and xanthomatosis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11348881     DOI: 10.1161/01.atv.21.5.825

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  13 in total

1.  The role of CD4+CD25+ regulatory T cells in macrophage-derived foam-cell formation.

Authors:  Jing Lin; Ming Li; Zhixiao Wang; Shaolin He; Xuming Ma; Dazhu Li
Journal:  J Lipid Res       Date:  2009-12-10       Impact factor: 5.922

2.  Eicosapentaenoic acid and docosahexaenoic acid regulate modified LDL uptake and macropinocytosis in human macrophages.

Authors:  James E McLaren; Daryn R Michael; Irina A Guschina; John L Harwood; Dipak P Ramji
Journal:  Lipids       Date:  2011-08-07       Impact factor: 1.880

3.  Macrophage-targeted photodynamic therapy: scavenger receptor expression and activation state.

Authors:  Q Liu; M R Hamblin
Journal:  Int J Immunopathol Pharmacol       Date:  2005 Jul-Sep       Impact factor: 3.219

Review 4.  Atherosclerosis and interferon-γ: new insights and therapeutic targets.

Authors:  Iryna Voloshyna; Michael J Littlefield; Allison B Reiss
Journal:  Trends Cardiovasc Med       Date:  2013-08-02       Impact factor: 6.677

5.  Microglial activation by uptake of fDNA via a scavenger receptor.

Authors:  Yuekui Li; Ling Liu; Dongge Liu; S Woodward; Steven W Barger; Robert E Mrak; W Sue T Griffin
Journal:  J Neuroimmunol       Date:  2004-02       Impact factor: 3.478

6.  TGF-β inhibits the uptake of modified low density lipoprotein by human macrophages through a Smad-dependent pathway: a dominant role for Smad-2.

Authors:  Daryn R Michael; Rebecca C Salter; Dipak P Ramji
Journal:  Biochim Biophys Acta       Date:  2012-06-13

7.  Conjugated linoleic acid induces an atheroprotective macrophage MΦ2 phenotype and limits foam cell formation.

Authors:  Monica de Gaetano; Kawthar Alghamdi; Simone Marcone; Orina Belton
Journal:  J Inflamm (Lond)       Date:  2015-02-19       Impact factor: 4.981

8.  Differential regulation of macropinocytosis in macrophages by cytokines: implications for foam cell formation and atherosclerosis.

Authors:  Daryn R Michael; Tim G Ashlin; Charlotte S Davies; Hayley Gallagher; Thomas W Stoneman; Melanie L Buckley; Dipak P Ramji
Journal:  Cytokine       Date:  2013-06-20       Impact factor: 3.861

9.  M1- and M2-Type Macrophage Responses Are Predictive of Adverse Outcomes in Human Atherosclerosis.

Authors:  Monica de Gaetano; Daniel Crean; Mary Barry; Orina Belton
Journal:  Front Immunol       Date:  2016-07-19       Impact factor: 7.561

10.  The TNF-like protein 1A-death receptor 3 pathway promotes macrophage foam cell formation in vitro.

Authors:  James E McLaren; Claudia J Calder; Brian P McSharry; Keith Sexton; Rebecca C Salter; Nishi N Singh; Gavin W G Wilkinson; Eddie C Y Wang; Dipak P Ramji
Journal:  J Immunol       Date:  2010-04-21       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.